Related Experiment Video
Updated: Mar 23, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Androgen receptor in male breast cancer
Beata Sas-Korczynska1, Aagnieszka Adamczyk, Joanna Niemiec
1Beata Sas-Korczynska MD, PhD, Oncology Clinic - Department of Breast and Chest Cancer, Maria Skłodowska-Curie Memorial Cancer Center, and Institute of Oncology, Krakow Branch, Garncarska 11, 31-115 Krakow, Poland, tel. +48 12 634 83 63, fax: +48 12 423 10 76,
Abstract:
We present the androgen receptor (AR) status in 32 breast cancers diagnosed in male patients. Androgen receptor expression was found in 62.5% tumors and it was more frequent (85% of cases) in estrogen-positive tumours. The analyses of its impact on treatment results showed that AR immmunopositivity is a prognostic factor for overall survival, and AR immunonegativity is also correlated with worse prognosis (distant metastases developed more frequently and earlier).
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

